A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : TNF-alpha

Search Conditions:
Search Keyword : TNF-alpha
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TNF-alpha
Appearance Frequency: 40938 time(s)
Long forms: 23

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
tumor necrosis factor-alpha
(40894 times)
Allergy and Immunology
(6142 times)
IL-6 (6211 times)
IL-1beta (5149 times)
LPS (4826 times)
1985 Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
alpha-tumor necrosis factor
(8 times)
Obstetrics
(3 times)
IL-1beta (2 times)
AM (1 time)
BAL (1 time)
2000 Effects of nickel sulfate on pulmonary natural immunity in Wistar rats.
Tumor necrosis factor-alpha/cachectin
(5 times)
Allergy and Immunology
(2 times)
anti-hTNF-alpha (1 time)
Bo rIFN-gamma (1 time)
BP (1 time)
1987 Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
Transforming necrosis factor-alpha
(4 times)
Obesity
(1 time)
CRP (1 time)
ELISA (1 time)
ICAM-I (1 time)
1999 Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes.
transforming growth factor-alpha
(3 times)
Biochemistry
(2 times)
COX-2 (2 times)
CM (1 time)
i.p (1 time)
2008 Accelerated Ulcer Healing and Resistance to Ulcer Recurrence with Gastroprotectants in Rat Model of Acetic Acid-induced Gastric Ulcer.
tumor necrosis factor receptor-alpha
(3 times)
Science
(1 time)
eNOS (1 time)
HE (1 time)
HUVECs (1 time)
1997 Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
tumor necrosis growth factor-alpha
(3 times)
Immune System
(1 time)
bFGF (2 times)
HGF (2 times)
VEGF (2 times)
2000 Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
Treated with Antitumor Necrosis Factor-Alpha
(2 times)
Medicine
(1 time)
--- 2014 Anti-TNF-alpha and risk of infections: the experience in one center.
tumor nuclear factor-alpha
(2 times)
Parasitology
(1 time)
CRP (1 time)
CVD (1 time)
IL (1 time)
2010 Leishmanicidal activity of Himatanthus sucuuba latex against Leishmania amazonensis.
10  Anti-Tnf-alpha/FNAB/PC-Au for protein biomarker
(1 time)
Biotechnology
(1 time)
FNAB (1 time)
PBS-T20 (1 time)
PC (1 time)
2017 On-chip electrochemical immunoassay platform for specific protein biomarker estimation in undiluted serum using off-surface membrane matrix.
11  inflammation-tumor necrosis factor-alpha
(1 time)
Endocrinology
(1 time)
BMI (1 time)
CV (1 time)
hs-CRP (1 time)
2015 Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors.
12  non-smokers.Tumor necrosis factor-alpha
(1 time)
Pulmonary Medicine
(1 time)
BAL (1 time)
COPD (1 time)
IL-6 (1 time)
2014 Compartment differences of inflammatory activity in chronic obstructive pulmonary disease.
13  production--tumour necrosis factor-alpha
(1 time)
Virology
(1 time)
EIAV (1 time)
HIV (1 time)
IFN-alpha (1 time)
1997 Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia.
14  T cell, could activate neither macrophage production of inflammatory cytokines
(1 time)
Allergy and Immunology
(1 time)
--- 1996 Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice.
15  thymus and spleen weights as well as serum necrosis factor-alpha
(1 time)
Biochemistry
(1 time)
IL-2 (1 time)
MW (1 time)
Se (1 time)
2016 Anti-tumor and immunomodulatory activity of selenium (Se)-polysaccharide from Se-enriched Grifola frondosa.
16  treatment strategies for Crohn's disease including antitumor necrosis factor-alpha
(1 time)
Pediatrics
(1 time)
GH (1 time)
IGF (1 time)
IL-6 (1 time)
2011 The role of growth hormone and insulin-like growth factor-1 in Crohn's disease: implications for therapeutic use of human growth hormone in pediatric patients.
17  tube dilution method, lymphocyte proliferation, and pro-inflammatory cytokines
(1 time)
Pharmacology
(1 time)
--- 2015 Immunosuppressive potential of Botryosphaeria dothidea, an endophyte isolated from Kigelia africana.
18  tumor necreactive oxygen speciesis factor-alpha
(1 time)
Pharmacology
(1 time)
AD (1 time)
COX-2 (1 time)
GCLM (1 time)
2017 L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: Involvement of NF-kappaB inhibition and Nrf2 pathway activation.
19  tumor necrosis alpha-factor
(1 time)
Medicine
(1 time)
--- 1996 [Correlation between histocompatibility antigens, tumor necrosis factor-alpha, and HIV infection].
20  tumor necrosis factor-alpha expression
(1 time)
Biochemistry
(1 time)
IL-1 (1 time)
1997 Interleukin-1 stimulates tumor necrosis factor-alpha (TNF-alpha) release from cytotrophoblastic BeWo cells independently of induction of the TNF-alpha mRNA.
21  Tumor Necrosis Factor-alpha serum concentration
(1 time)
Biology
(1 time)
--- 1996 Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudine.
22  tumour necrosis factor-alpha production
(1 time)
Cell Biology
(1 time)
IA (1 time)
2017 Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.
23  type and number of infiltrating cells, changes in protein, cytokine
(1 time)
Dermatology
(1 time)
DNFB (1 time)
EGFRIs (1 time)
SCF (1 time)
2011 Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.